Iron status in women with and without gestational diabetes mellitus

被引:95
作者
Afkhami-Ardekani, Mohammad [1 ]
Rashidi, Maryam [1 ]
机构
[1] Shahid Sadoughi Univ Med Sci & Hlth Serv, Diabet Res Ctr, Yazd, Iran
关键词
Gestational diabetes mellitus; Serum ferritin; Serum iron; SERUM FERRITIN CONCENTRATION; MATERNAL HEMOGLOBIN; GASTROINTESTINAL-TRACT; BIRTH-WEIGHT; INSULIN; MEN; PREGNANCY; ANEMIA; RISK; 2ND-TRIMESTER;
D O I
10.1016/j.jdiacomp.2007.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Gestational diabetes mellitus (GDM) affects approximately 7% of all pregnancies. Pregnancy, mostly because of the mitochondria-rich placenta, is a condition that favors oxidative stress. A transitional metal, especially iron, which is particularly abundant in the placenta, is important in the production of free radicals. Also, studies have shown that free radicals have a role in GDM. As there are little data about iron status in GDM, this study was performed to compare iron status in GDM and control group. Research Design and Methods: In this case-control study, 34 women with diagnosed GDM were compared with 34 non-GDM women in the control group at 24-28 weeks of pregnancy in terms of iron status, including ferritin, serum iron, total iron-binding capacity (TIBC), hemoglobin (Hb), mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH). Results: In this study, concentration of serum ferritin, iron, transferrin saturation and hemoglobin, MCV, and MCH was significantly higher in the GDM group and TIBC was significantly lower in this group (P<.05). No significant association was observed with the other variables including familial history of diabetes and GDM. Conclusion: Our findings indicate an association between increased iron status and GDM. The role of iron excess from iron supplementation in the pathogenesis of GDM needs to be examined. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 39 条
[1]   Erosive injury to the upper gastrointestinal tract in patients receiving iron medication - An underrecognized entity [J].
Abraham, SC ;
Yardley, JH ;
Wu, TT .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (10) :1241-1247
[2]  
American Diabetes Association, 2004, Diab Rev (Alexandria, VA), V27, pS88, DOI [10.2337/diacare.27.2007.s88, DOI 10.2337/DIACARE.27.2007.S88]
[3]  
[Anonymous], 2007, DIABETES CARE, V30, P4, DOI [DOI 10.2337/DC07-S004, 10.2337/dc07-S004]
[4]  
Ascherio A, 2001, CIRCULATION, V103, P52
[5]   New aspects of the insulin resistance syndrome: impact on haematological parameters [J].
Barbieri, M ;
Ragno, E ;
Benvenuti, E ;
Zito, GA ;
Corsi, A ;
Ferrucci, L ;
Paolisso, G .
DIABETOLOGIA, 2001, 44 (10) :1232-1237
[6]  
Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S
[7]   Serum ferritin as a component of the insulin resistance syndrome [J].
Fernández-Real, JM ;
Ricart-Engel, W ;
Arroyo, E ;
Balançá, R ;
Casamitjana-Abella, R ;
Cabrero, D ;
Fernández-Castañer, M ;
Soler, J .
DIABETES CARE, 1998, 21 (01) :62-68
[8]   Cross-talk between iron metabolism and diabetes [J].
Fernández-Real, JM ;
López-Bermejo, A ;
Ricart, W .
DIABETES, 2002, 51 (08) :2348-2354
[9]   Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137
[10]   Diabetes and serum ferritin concentration among US adults [J].
Ford, ES ;
Cogswell, ME .
DIABETES CARE, 1999, 22 (12) :1978-1983